To confirm that MLL/AF9-OVA leukemia cells were engrafted and then eliminated in the wild-type recipients, we transplanted 3 × 104 MLL/AF9-OVA leukemia cells into another set of wild-type recipients (n = 7, Exp. The gene discussed is KMT2A; the disease is leukemia.